Search Tag: heart failure

Cardiology Management

Machine Learning Helps Predict Risk of Heart Failure

2019 20 Sep

Heart failure is a common complication in patients suffering from Type 2 Diabetes (T2D). Recently, new medicines have been developed to offset these risks; however, finding effective strategies to identify which T2D patients are most at risk has been difficult.    Researchers at Brigham and Women’s Hospital and UT Southwestern Medical Centre have... Read more

Cardiology Management

#ESCCongress: PARAGON-HF Trial Misses Endpoint

2019 01 Sep

Findings from the PARAGON-HF trial were presented in the first hot-line session at the ESC Congress today in Paris. Investigators from Brigham and Women's Hospital presented the results of the Prospective Comparison of ARNI with ARB Global Outcome in HF With Preserved Ejection Fraction (PARAGON-HF). This is the largest, randomised clinical trial... Read more

Cardiology Management

#ESCCongress Preview: DAPA-HF Trial

2019 29 Aug

The DAPA-HF trial is the first heart failure outcomes trial with dapagliflozin, an SGLT2 inhibitor, in patients with and without Type-2 diabetes. Findings from the trial will be presented at the ESC Congress next week.  DAPA-HF is an international, multi-centre, parallel-group, randomised, double-blind trial in patients with heart failure... Read more

Executive Health Management

The Future of Cardiovascular Disease Treatment and Management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and... Read more

Cardiology Management

Inotropic Agents for Heart Failure - Wishful Thinking?

2019 26 Aug

Summary: Calcium activation and calcium sensitivity in the failing myocardium.   Historically, treatment of heart failure with inotropic agents started with the employment of extracts of foxglove, which contained a mixture of cardiac glycosides. With their low therapeutic margin due to a resulting ionic dysbalance though, cardiac glycosides... Read more

Cardiology Management

#ESCCongress Preview: PARAGON-HF Trial

2019 10 Aug

Topline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September.  The  PARAGON-HF trial  in heart failure patients with preserved ejection fraction (HFPEF) investigates the safety and efficacy of sacubitril/valsartan versus the active comparator... Read more

Cardiology Management

Heart Failure 2020

2020 23 May

Find ESC on Social Media Read more

Cardiology Management

Smoking and Risk of Cardiovascular Disease

2019 08 Jul

The most in-depth study in the world on smoking risks to cardiovascular health reveals 17 Australian smokers die each day from heart attacks, strokes and other cardiovascular conditions.  The Australian National University (ANU) conducted a study, in partnership with the Heart Foundation and the Sax Institute, with 190,000 Australian smokers and... Read more

Cardiology Management

EuroPCR 2020

2020 19 May

Find PCR on Social Media   Read more

Cardiology Management

Shared Decision Making and Cardiovascular Care

2019 20 Jun

As the focus on patient-centred care increases, healthcare authorities are trying their best to establish progressive programmes and policies that encourage clinicians to integrate approaches that consider patient needs first. For example, US Centers for Medicare and Medicaid have embedded policies in 2019 that offer incentives to healthcare providers... Read more